BRIEF published on 12/04/2025 at 20:20, 11 months 16 days ago Galimedix Therapeutics dévoile des résultats prometteurs de phase 1 pour le GAL-101 Résultats De La Phase 1 GAL-101 Traitement De La Maladie D'Alzheimer Barrière Hémato-encéphalique Planification De La Phase 2
BRIEF published on 12/04/2025 at 19:35, 11 months 16 days ago Emerging Risks in the Gold Market: The Case for New Verification Technologies Financial Stability Gold Market SMX Innovations Verification Technology Counterfeit Risk
BRIEF published on 12/04/2025 at 19:35, 11 months 16 days ago Risques émergents sur le marché de l'or : plaidoyer pour de nouvelles technologies de vérification Stabilité Financière Marché De L'or Innovations SMX Technologie De Vérification Risque De Contrefaçon
BRIEF published on 12/04/2025 at 19:18, 11 months 16 days ago État des droits de vote et actions de MERCIALYS Droits De Vote Capital Social Paris Assemblée Générale MERCIALYS
BRIEF published on 12/04/2025 at 19:18, 11 months 16 days ago Status of voting rights and shares of MERCIALYS Share Capital Voting Rights Paris General Assembly MERCIALYS
BRIEF published on 12/04/2025 at 19:15, 11 months 16 days ago SCHOTT Pharma Reports Preliminary 2025 Financial Results EBITDA Margin Mid-term Guidance Drug Delivery Systems Preliminary Results 2025 Financial Forecast 2026
BRIEF published on 12/04/2025 at 19:15, 11 months 16 days ago SCHOTT Pharma publie ses résultats financiers préliminaires pour 2025 Marge D'EBITDA Systèmes D'administration De Médicaments Orientations À Mi-parcours Résultats Préliminaires 2025 Prévisions Financières 2026
BRIEF published on 12/04/2025 at 18:58, 11 months 16 days ago SCHOTT Pharma Revises 2026 Fiscal Outlook and Mid-Term Guidance Revenue Growth EBITDA Margin SCHOTT Pharma Mid-term Guidance 2026 Outlook
BRIEF published on 12/04/2025 at 18:58, 11 months 16 days ago SCHOTT Pharma revoit ses perspectives fiscales pour 2026 et ses prévisions à moyen terme SCHOTT Pharma Croissance Des Revenus Marge D'EBITDA Perspectives 2026 Orientations À Mi-parcours
BRIEF published on 12/04/2025 at 18:50, 11 months 16 days ago Démarrage du Premier Puits d'Hydrogène Naturel par FDE Développement Durable FDE Hydrogène Naturel Puits Profond Région Grand Est
Published on 11/20/2026 at 14:50, 1 day 1 hour ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 1 day 2 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 1 day 3 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 1 day 3 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 17 hours 2 minutes ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 18 hours 7 minutes ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 19 hours 11 minutes ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 19 hours 58 minutes ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 22 hours 12 minutes ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 22 hours 12 minutes ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 23 hours 12 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 23 hours 12 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 1 day 21 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR